Tevogen Bio Holdings Inc. (NASDAQ:TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday announcement regarding operational updates. Here’s what you need to know. What To Know: Shortly before the market close on Friday, Tevogen said it’s close to finalizing a deal with CD8 Technology to establish a comprehensive, turn-key facility to support both pre-clinical research and GMP manufacturing capabilities. The facility is expected to be staffed by Tevogen, providing necessary infrastructure to advance the company’s pipeline. In connection with the announcement, …